288 related articles for article (PubMed ID: 20888252)
21. Targeted drug delivery for treatment and imaging of glioblastoma multiforme.
Stukel JM; Caplan MR
Expert Opin Drug Deliv; 2009 Jul; 6(7):705-18. PubMed ID: 19538036
[TBL] [Abstract][Full Text] [Related]
22. Convection-enhanced delivery of interleukin-13 receptor-directed cytotoxin for malignant glioma therapy.
Kioi M; Husain SR; Croteau D; Kunwar S; Puri RK
Technol Cancer Res Treat; 2006 Jun; 5(3):239-50. PubMed ID: 16700620
[TBL] [Abstract][Full Text] [Related]
23. Developing new methods for the treatment of malignant brain tumours: local delivery of anti-neoplastic agents using biodegradable polymers.
Olivi A; DiMeco F; Bohan E; Brem H
Forum (Genova); 2000; 10(2):152-65. PubMed ID: 10875976
[TBL] [Abstract][Full Text] [Related]
24. Effects of drug efflux on convection-enhanced paclitaxel delivery to malignant gliomas: technical note.
Tanner PG; Holtmannspötter M; Tonn JC; Goldbrunner R
Neurosurgery; 2007 Oct; 61(4):E880-2; discussion E882. PubMed ID: 17986926
[TBL] [Abstract][Full Text] [Related]
25. Novel therapies for malignant gliomas: a local affair?
Rainov NG; Söling A; Heidecke V
Neurosurg Focus; 2006 Apr; 20(4):E9. PubMed ID: 16709040
[TBL] [Abstract][Full Text] [Related]
26. Treatment of malignant gliomas: radiotherapy, chemotherapy and integration of new targeted agents.
Nieder C; Grosu AL; Mehta MP; Andratschke N; Molls M
Expert Rev Neurother; 2004 Jul; 4(4):691-703. PubMed ID: 15853588
[TBL] [Abstract][Full Text] [Related]
27. Convection enhanced drug delivery of novel therapeutic agents to malignant brain tumors.
Ferguson S; Lesniak MS
Curr Drug Deliv; 2007 Apr; 4(2):169-80. PubMed ID: 17456036
[TBL] [Abstract][Full Text] [Related]
28. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
29. Longitudinal assessment of regional directed delivery in a rodent malignant glioma model.
Kondo A; Goldman S; Lulla RR; Mania-Farnell B; Vanin EF; Sredni ST; Rajaram V; Soares MB; Tomita T
J Neurosurg Pediatr; 2009 Dec; 4(6):592-8. PubMed ID: 19951051
[TBL] [Abstract][Full Text] [Related]
30. Convection enhanced delivery of carmustine to the murine brainstem: a feasibility study.
Sewing AC; Caretti V; Lagerweij T; Schellen P; Jansen MH; van Vuurden DG; Idema S; Molthoff CF; Vandertop WP; Kaspers GJ; Noske DP; Hulleman E
J Neurosci Methods; 2014 Dec; 238():88-94. PubMed ID: 25263805
[TBL] [Abstract][Full Text] [Related]
31. Local drug delivery in recurrent malignant gliomas.
Boiardi A; Eoli M; Salmaggi A; Lamperti E; Botturi A; Solari A; Di Meco F; Broggi G; Silvani A
Neurol Sci; 2005 May; 26 Suppl 1():S37-9. PubMed ID: 15883691
[TBL] [Abstract][Full Text] [Related]
32. Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience.
Attenello FJ; Mukherjee D; Datoo G; McGirt MJ; Bohan E; Weingart JD; Olivi A; Quinones-Hinojosa A; Brem H
Ann Surg Oncol; 2008 Oct; 15(10):2887-93. PubMed ID: 18636295
[TBL] [Abstract][Full Text] [Related]
33. Convection-enhanced delivery in the treatment of malignant glioma.
Lopez KA; Waziri AE; Canoll PD; Bruce JN
Neurol Res; 2006 Jul; 28(5):542-8. PubMed ID: 16808887
[TBL] [Abstract][Full Text] [Related]
34. Convection-enhanced delivery for the treatment of glioblastoma.
Vogelbaum MA; Aghi MK
Neuro Oncol; 2015 Mar; 17 Suppl 2(Suppl 2):ii3-ii8. PubMed ID: 25746090
[TBL] [Abstract][Full Text] [Related]
35. Local convection-enhanced delivery of chemotherapeutic agent transiently opens blood-brain barrier and improves efficacy of systemic chemotherapy in intracranial xenograft tumor model.
Nakamura T; Saito R; Sugiyama S; Sonoda Y; Kumabe T; Tominaga T
Cancer Lett; 2011 Nov; 310(1):77-83. PubMed ID: 21763069
[TBL] [Abstract][Full Text] [Related]
36. Convection-Enhanced Delivery for Management of Malignant Gliomas.
Prabhu SS
Prog Neurol Surg; 2018; 32():152-158. PubMed ID: 29990981
[TBL] [Abstract][Full Text] [Related]
37. Induction of hyperintense signal on T2-weighted MR images correlates with infusion distribution from intracerebral convection-enhanced delivery of a tumor-targeted cytotoxin.
Sampson JH; Raghavan R; Provenzale JM; Croteau D; Reardon DA; Coleman RE; Rodríguez Ponce I; Pastan I; Puri RK; Pedain C
AJR Am J Roentgenol; 2007 Mar; 188(3):703-9. PubMed ID: 17312057
[TBL] [Abstract][Full Text] [Related]
38. Phase I trial of intracerebral convection-enhanced delivery of carboplatin for treatment of recurrent high-grade gliomas.
Wang JL; Barth RF; Cavaliere R; Puduvalli VK; Giglio P; Lonser RR; Elder JB
PLoS One; 2020; 15(12):e0244383. PubMed ID: 33373402
[TBL] [Abstract][Full Text] [Related]
39. Convection-enhanced delivery of targeted toxins for malignant glioma.
Hall WA; Sherr GT
Expert Opin Drug Deliv; 2006 May; 3(3):371-7. PubMed ID: 16640497
[TBL] [Abstract][Full Text] [Related]
40. Locoregional infusion of IL13Rα2-specific immunotoxins in children and adults with high-grade glioma.
Rechberger JS; Daniels DJ
Ther Deliv; 2022 Aug; 13(8):385-389. PubMed ID: 35872639
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
